News

Published on 13 Jul 2023 on Zacks via Yahoo Finance

AVROBIO (AVRO) to Explore Strategic Options, Stock Rises 46%


Article preview image

AVROBIO AVRO announced completing a review of its business encompassing the status of its programs, resources and capabilities as part of its reprioritization efforts. To this extent, the company has decided to halt the development programs of its investigational gene therapy candidates.

Per AVROBIO, the potential strategic alternatives may include, but are not limited to, an acquisition, merger, business combination or other transaction under its evaluation process. In the event of AVROBIO pursuing a transaction, the company refrained from giving its shareholders any assurance that such transaction will be completed on attractive terms.

AVRO has not provided any anticipated date of completion of its evaluation process. Additionally, the company is reluctant to disclose further developments unless and until it is determined that further disclosure is appropriate or necessary.

NASDAQ.AVRO price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Is AVROBIO (AVRO) Stock Outpacing Its Medical Peers This Year?

The Medical group has plenty of great stocks, but investors should always be looking for companie...

Zacks via Yahoo Finance 8 Nov 2023

Is AVROBIO (AVRO) Outperforming Other Medical Stocks This Year?

Investors interested in Medical stocks should always be looking to find the best-performing compa...

Zacks via Yahoo Finance 23 Oct 2023

Has AVROBIO (AVRO) Outpaced Other Medical Stocks This Year?

The Medical group has plenty of great stocks, but investors should always be looking for companie...

Zacks via Yahoo Finance 6 Oct 2023

AVROBIO (AVRO) to Explore Strategic Options, Stock Rises 46%

AVROBIO AVRO announced completing a review of its business encompassing the status of its program...

Zacks via Yahoo Finance 13 Jul 2023

The Petri Dish: FDA delays Sarepta decision; Novartis buys Avrobio drug - Boston Business Journal

Here's The Petri Dish, a roundup of news that may get overlooked amid the influx of health care...

The Business Journals 25 May 2023

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.42% By Investing.com

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.42%

Investing.com 22 May 2023

Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving...

Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Movin...

Investing.com 22 May 2023

Avrobio Touts Positive Data Gene Therapy Trial For Cystinosis, Showing Treatment Durability Of Up To...

Avrobio Inc (NASDAQ: AVRO) announced follow-up data demonstrating a durable treatment effect acro...

Benzinga via Yahoo Finance 18 May 2023

U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.34%

U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.34%

Investing.com 17 May 2023

8 Best Penny Stocks To Buy Under $1.00

Penny stocks are often found in emerging industries or in industries that require a long period o...

GoBankingRates via AOL 18 Jan 2023